Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023
PHILADELPHIA, Feb. 14, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, March 1, 2023 at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2022.
Related news for (FOLD)
- Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
- Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
- Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
- Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
- 24/7 Market News Snapshot 17 October, 2024 – Amicus Therapeutics, Inc (NASDAQ:FOLD)
